Search Results
Viewing: 111-120 of 335 | All
News
Cardinal Health Donates $1 Million to Nationwide Childrens Hospital Supporting the Work of its Tissue Engineering Program
Cardinal Health recently donated $1 million to Nationwide Children’s Hospital to help advance the work and research of its Tissue Engineering Program.
News
From Bench to Bedside: Patient with Duchenne Muscular Dystrophy Receives First Dose of Gene Therapy Developed at Nationwide Children’s Hospital
In a landmark moment for the Abigail Wexner Research Institute at Nationwide Children’s, a 5-year-old from Bellefontaine, Ohio, received the first dose of a recently approved gene therapy for Duchenne muscular dystrophy at Nationwide Children’s Hospital, where the therapy was invented and initially tested.
News
Nationwide Children’s Hospital Tops Forbes List of ‘America’s Best Employers for Women’
Nationwide Children’s Hospital has ranked first on Forbes’ 2024 “America’s Best Employers for Women” list.
News
Nationwide Children’s Hospital Becomes Certified Site for Gene Therapy for Transfusion-Dependent Beta Thalassemia
Nationwide Children’s Hospital has been designated a qualified treatment center for Zynteglo® (betibeglogene autotemcel), a a gene therapy approved for the treatment of people with beta thalassemia who require regular red blood cell transfusions.
Article
Davenport Lab
The SLEEP Empowers Lab, led by Mattina Davenport, PhD, focuses on improving community sleep health through community-driven research and initiatives to improve sleep health equity by empowering populations.
News
Catherine Krawczeski, MD, Named Chief of the Department of Pediatrics at Nationwide Children’s Hospital
Catherine Dent Krawczeski, MD, has been named Physician-in-Chief and Chief of the Department of Pediatrics at Nationwide Children’s Hospital. Dr. Krawczeski will also serve as Chair of Pediatrics at The Ohio State University College of Medicine, pending approval from The Ohio State University Board of Trustees. Dr. Krawczeski will begin this new role in Summer 2022.
News
1 Year In, the CCDI Molecular Characterization Initiative Has Analyzed Samples From Over 1,000 Patients
The CCDI Molecular Characterization Initiative (MCI) is a project that aims to collect, analyze and report clinical and molecular data and is currently supporting Children’s Oncology Group (COG)-affiliated clinicians in choosing the best treatment for each child through precision diagnosis. This program is part of the National Cancer Institute (NCI) Childhood Cancer Data Initiative (CCDI), a national commitment and community-wide effort to harness data in ways that speed up progress in childhood cancer. Announced last year, the MCI is a collaboration among NCI, part of the National Institutes of Health, COG and Nationwide Children’s Hospital and is the largest initiative of its kind in the United States.
News
Saliva, Genomic Analysis Used to Identify Promising Biomarkers for Persistent Post-Concussive Symptoms in Children
In a study published in Frontiers in Public Health, researchers with the Center for Injury Research and Policy, Division of Sports Medicine, and the Steve and Cindy Rasmussen Institute for Genomic Medicine at Nationwide Children’s Hospital have demonstrated a method by which increased risk of persistent post-concussive symptoms (PPCS) in children with concussion can be identified. This could allow families and their care teams to better assess recovery time of children with concussion.
News
Study Finds High Mortality Rates of Youths Previously Incarcerated in the Juvenile Legal System
New research from the Abigail Wexner Research Institute at Nationwide Children’s Hospital finds that youth aged 11 to 21 years, who have been previously incarcerated in the juvenile legal system, are 5.9 times more likely than the general population to experience early mortality. The report, which describes a cohort study of 3645 previously incarcerated youths in Ohio’s juvenile legal system, appears this week in JAMA Network Open.
News
New Study Finds Sharp Increase in Nicotine Pouch Ingestions Among Young Children
A new study reveals that ingestions of nicotine pouches by young children have surged in recent years. Our researcher, along the Central Ohio Poison Center experts analyzed calls to U.S. poison centers and found an alarming 763% increase in the rate of reported nicotine pouch ingestions among children younger than 6 years old from 2020 to 2023.